| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.01e-05 | 20 | 166 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 IPO5 RANBP2 RIN3 RGPD8 DOCK10 ASB14 RAB11FIP1 MEGF9 RABGAP1L RGPD3 | 8.06e-05 | 321 | 166 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 IPO5 RANBP2 RIN3 RGPD8 DOCK10 ASB14 RAB11FIP1 MEGF9 RABGAP1L RGPD3 | 2.20e-04 | 360 | 166 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.20e-04 | 36 | 166 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 IPO5 RANBP2 RIN3 RGPD8 PPP2R2D KALRN CALU DOCK10 APC PSMD2 TBC1D8B VAC14 PPP2R2B PPP2R2C RABGAP1L RGPD3 RASGEF1B AKAP11 FAM47E CABIN1 RPL5 ELP4 RGPD5 PHACTR1 | 2.85e-04 | 1418 | 166 | 25 | GO:0030234 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.20e-10 | 20 | 163 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.59e-07 | 9 | 163 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 7.61e-07 | 10 | 163 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.54e-06 | 13 | 163 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.54e-06 | 14 | 163 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.56e-05 | 195 | 163 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.25e-05 | 201 | 163 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 IPO5 RANBP2 RGPD8 KALRN TTC21A APC PTPN22 SPG11 TEX15 HUWE1 NUP35 CEP350 PPP2R2B GRXCR2 RGPD3 MDC1 AHR AKAP11 FAM47E SPIDR RGPD5 | 5.02e-05 | 1091 | 163 | 22 | GO:0033365 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.41e-07 | 18 | 167 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.68e-07 | 8 | 167 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.31e-07 | 20 | 167 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 7.95e-07 | 10 | 167 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear pore | 1.51e-06 | 101 | 167 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 IPO5 RANBP2 RGPD8 APC NUP35 MYOF HABP4 RNF123 MLIP DST RBMX2 PGRMC2 RGPD3 NXF1 EPHA3 RGPD5 | 2.67e-06 | 560 | 167 | 17 | GO:0005635 |
| GeneOntologyCellularComponent | annulate lamellae | 3.70e-06 | 14 | 167 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.11e-05 | 21 | 167 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear membrane | RGPD4 IPO5 RANBP2 RGPD8 APC NUP35 MYOF HABP4 RNF123 RBMX2 RGPD3 EPHA3 | 2.52e-05 | 349 | 167 | 12 | GO:0031965 |
| GeneOntologyCellularComponent | inclusion body | 8.50e-05 | 90 | 167 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 1.89e-04 | 3 | 167 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 3.74e-04 | 18 | 167 | 3 | GO:0000159 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 9.32e-04 | 6 | 167 | 2 | GO:0005593 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.47e-05 | 16 | 137 | 4 | MP:0003701 | |
| Domain | Ran_BP1 | 3.82e-08 | 12 | 165 | 5 | PF00638 | |
| Domain | RANBD1 | 3.82e-08 | 12 | 165 | 5 | PS50196 | |
| Domain | RanBD | 6.16e-08 | 13 | 165 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 6.16e-08 | 13 | 165 | 5 | IPR000156 | |
| Domain | Grip | 1.85e-06 | 11 | 165 | 4 | SM00755 | |
| Domain | GRIP | 1.85e-06 | 11 | 165 | 4 | PF01465 | |
| Domain | TPR_REGION | RGPD4 RANBP2 RGPD8 TTC21A TRANK1 RGPD3 TANC1 CABIN1 CLUH RGPD5 | 2.12e-06 | 165 | 165 | 10 | PS50293 |
| Domain | TPR | RGPD4 RANBP2 RGPD8 TTC21A TRANK1 RGPD3 TANC1 CABIN1 CLUH RGPD5 | 2.12e-06 | 165 | 165 | 10 | PS50005 |
| Domain | PP2A_PR55_CS | 2.69e-06 | 4 | 165 | 3 | IPR018067 | |
| Domain | PP2A_PR55 | 2.69e-06 | 4 | 165 | 3 | IPR000009 | |
| Domain | PR55_2 | 2.69e-06 | 4 | 165 | 3 | PS01025 | |
| Domain | PR55_1 | 2.69e-06 | 4 | 165 | 3 | PS01024 | |
| Domain | GRIP_dom | 2.75e-06 | 12 | 165 | 4 | IPR000237 | |
| Domain | GRIP | 2.75e-06 | 12 | 165 | 4 | PS50913 | |
| Domain | TPR-contain_dom | 7.54e-06 | 150 | 165 | 9 | IPR013026 | |
| Domain | TPR | 1.93e-05 | 129 | 165 | 8 | SM00028 | |
| Domain | Rab_bind | 2.31e-05 | 7 | 165 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.31e-05 | 7 | 165 | 3 | IPR032023 | |
| Domain | TPR_repeat | 2.41e-05 | 133 | 165 | 8 | IPR019734 | |
| Domain | TPR-like_helical_dom | RGPD4 RANBP2 RGPD8 TTC21A TRANK1 RGPD3 TANC1 CABIN1 CLUH RGPD5 | 4.35e-05 | 233 | 165 | 10 | IPR011990 |
| Domain | - | 7.76e-05 | 10 | 165 | 3 | 1.10.220.60 | |
| Domain | - | 9.56e-05 | 207 | 165 | 9 | 1.25.40.10 | |
| Domain | FN3 | 2.43e-04 | 185 | 165 | 8 | SM00060 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 KALRN DOCK10 PLEKHH1 FRMD6 NBEAL2 RABGAP1L RGPD3 OSBPL9 RGPD5 | 4.15e-04 | 426 | 165 | 12 | IPR011993 |
| Domain | FN3_dom | 5.50e-04 | 209 | 165 | 8 | IPR003961 | |
| Domain | fn3 | 5.99e-04 | 162 | 165 | 7 | PF00041 | |
| Domain | PAS_fold_3 | 1.05e-03 | 23 | 165 | 3 | IPR013655 | |
| Domain | PAS_3 | 1.05e-03 | 23 | 165 | 3 | PF08447 | |
| Domain | C2 | 1.09e-03 | 131 | 165 | 6 | PF00168 | |
| Domain | PAS-assoc_C | 1.20e-03 | 24 | 165 | 3 | IPR000700 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.58e-06 | 43 | 120 | 6 | MM14609 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.78e-06 | 73 | 120 | 7 | MM15126 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.93e-06 | 50 | 120 | 6 | MM14610 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.39e-05 | 18 | 120 | 4 | MM1549 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.73e-05 | 96 | 120 | 7 | MM14592 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.13e-05 | 40 | 120 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.41e-05 | 41 | 120 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.72e-05 | 42 | 120 | 5 | MM15039 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.74e-05 | 47 | 120 | 5 | MM14939 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 5.25e-05 | 48 | 120 | 5 | MM15069 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.81e-05 | 49 | 120 | 5 | MM14837 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 6.22e-05 | 117 | 120 | 7 | M19248 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 7.06e-05 | 51 | 120 | 5 | MM15151 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 7.94e-05 | 84 | 120 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 9.06e-05 | 86 | 120 | 6 | MM15413 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.02e-04 | 55 | 120 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.31e-04 | 58 | 120 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.31e-04 | 58 | 120 | 5 | MM14736 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.08e-04 | 100 | 120 | 6 | MM14561 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.26e-04 | 65 | 120 | 5 | MM15147 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 3.57e-04 | 155 | 120 | 7 | M522 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.60e-04 | 40 | 120 | 4 | MM15060 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.89e-04 | 73 | 120 | 5 | MM14948 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.87e-04 | 117 | 120 | 6 | MM15387 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 5.11e-04 | 271 | 120 | 9 | MM15406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 5.28e-04 | 19 | 120 | 3 | M47525 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 6.65e-04 | 82 | 120 | 5 | MM15394 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 7.07e-04 | 5 | 120 | 2 | M47966 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.15e-04 | 129 | 120 | 6 | MM14894 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 8.23e-04 | 22 | 120 | 3 | M47919 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 8.71e-04 | 234 | 120 | 8 | MM14898 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.02e-03 | 90 | 120 | 5 | M820 | |
| Pathway | REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE | 1.05e-03 | 6 | 120 | 2 | M27603 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.12e-03 | 92 | 120 | 5 | MM14951 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.29e-03 | 141 | 120 | 6 | MM15266 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.31e-03 | 193 | 120 | 7 | MM14890 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.49e-03 | 58 | 120 | 4 | M11980 | |
| Pubmed | IPO5 DCHS2 RELN CFAP91 ADAM19 KALRN POLR1C APC PSMD2 HUWE1 REV3L CPNE5 CBS CEP350 PLEKHH1 TARS3 RNF123 DST MEGF9 ASPA USP32 MAST1 PBX2 CABIN1 | 1.54e-08 | 1285 | 168 | 24 | 35914814 | |
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.82e-08 | 7 | 168 | 4 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.82e-08 | 7 | 168 | 4 | 11353387 | |
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 30944974 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.82e-08 | 7 | 168 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.82e-08 | 7 | 168 | 4 | 17372272 | |
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 38657106 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 21205196 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 18949001 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 25187515 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 8603673 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 26632511 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 24403063 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 23818861 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 23536549 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 12191015 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 22821000 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 20682751 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A RANBP2 ILF3 APC DDX56 HUWE1 NUP35 DDX50 MDC1 BRD7 MTREX RPL5 NXF1 RPAP2 | 3.51e-08 | 440 | 168 | 14 | 34244565 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.62e-08 | 8 | 168 | 4 | 21670213 | |
| Pubmed | 3.62e-08 | 8 | 168 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.62e-08 | 8 | 168 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.62e-08 | 8 | 168 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.62e-08 | 8 | 168 | 4 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 6.50e-08 | 9 | 168 | 4 | 18394993 | |
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 28100513 | ||
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 17887960 | ||
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 11553612 | ||
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 10601307 | ||
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 9733766 | ||
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 28877029 | ||
| Pubmed | IPO5 ILF3 BICRA CARS1 SLC7A2 DST DDX50 FRMD6 BRD7 AHR GOLIM4 MTREX TALDO1 RPL5 CLUH RPAP2 | 8.80e-08 | 634 | 168 | 16 | 34591612 | |
| Pubmed | 1.08e-07 | 10 | 168 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.08e-07 | 10 | 168 | 4 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.08e-07 | 10 | 168 | 4 | 8857542 | |
| Pubmed | 1.08e-07 | 10 | 168 | 4 | 21859863 | ||
| Pubmed | 1.69e-07 | 11 | 168 | 4 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.69e-07 | 11 | 168 | 4 | 35771867 | |
| Pubmed | 1.69e-07 | 11 | 168 | 4 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.63e-07 | 13 | 168 | 4 | 31427429 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 9480752 | ||
| Pubmed | 6.88e-07 | 15 | 168 | 4 | 14697343 | ||
| Pubmed | FLNC RANBP2 ZDBF2 NUP35 SLC7A2 DST PGRMC2 RGPD3 OSBPL9 TACC1 TANC1 TYW1 SLC39A14 ELP4 | 7.71e-07 | 568 | 168 | 14 | 37774976 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 TRPM4 HIF1A EOGT EPHA6 BICRA TTC21A DDX56 HUWE1 BTBD9 ZP3 PLEKHH1 PPP2R2C NT5C2 OSBPL9 MAST1 KATNIP TANC1 SPIDR PBX2 ZNF512 ZMAT1 RPAP2 | 8.96e-07 | 1489 | 168 | 23 | 28611215 |
| Pubmed | IPO5 DPP4 RANBP2 ILF3 CALU DOCK10 PSMD2 DDX56 ASPHD2 HUWE1 LMBRD2 CEP350 PARP4 DDX50 NBEAL2 PGRMC2 MARF1 GOLIM4 RPL5 RHOT1 | 1.04e-06 | 1168 | 168 | 20 | 19946888 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.09e-06 | 38 | 168 | 5 | 12791264 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | IPO5 FOXN2 COL12A1 ZNF112 DCC MYOF SLC7A2 DST OSBPL9 CABIN1 SENP7 | 1.73e-06 | 363 | 168 | 11 | 14691545 |
| Pubmed | IPO5 EPC2 EFL1 ILF3 EPHA6 BICRA KDM5C MECOM PSMD2 SKA2 SPG11 ZDBF2 DPH6 HABP4 SLC12A1 ZBED4 PGRMC2 BRD7 NT5C2 AHR NXF1 | 1.91e-06 | 1327 | 168 | 21 | 32694731 | |
| Pubmed | RGPD4 RPGRIP1 FLNC RANBP2 ILF3 RGPD8 UNCX PSMD2 SPG11 DCC SH3D21 CHRNB3 NUP35 MLIP DST DDX50 ZBED4 STARD9 RBMX2 RGPD3 MARF1 RGPD5 | 1.94e-06 | 1442 | 168 | 22 | 35575683 | |
| Pubmed | RPGRIP1 HIF1A ILF3 APC PSMD2 NR6A1 BTBD9 CHRNB3 DST RABGAP1L PGRMC2 BRD7 MAST1 KATNIP FGFR2 PBX2 ADIPOR2 PHACTR1 | 2.03e-06 | 1006 | 168 | 18 | 15226823 | |
| Pubmed | RGPD8 APC MECOM SPG11 ZDBF2 HUWE1 CEP350 PGRMC2 MDC1 TACC1 TANC1 TYW1 CLUH ELP4 RPAP2 | 3.06e-06 | 733 | 168 | 15 | 34672954 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | IPO5 ILF3 RGPD8 PSMD2 DDX56 ZDBF2 HUWE1 NUP35 PDE12 DST DDX50 PGRMC2 BRD7 OSBPL9 AKAP11 TACC1 TANC1 SLC39A14 TRMT5 ZNF512 CLUH RHOT1 | 3.50e-06 | 1496 | 168 | 22 | 32877691 |
| Pubmed | 3.59e-06 | 22 | 168 | 4 | 27717094 | ||
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 3.82e-06 | 7 | 168 | 3 | 25816751 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 4.24e-06 | 87 | 168 | 6 | 17148452 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPC2 RANBP2 HIF1A ILF3 SFSWAP POLR1C MECOM DDX56 MSANTD3 DST DDX50 TAF9B ZBED4 RBMX2 RGPD3 MDC1 MTREX CABIN1 RPL5 NXF1 | 4.87e-06 | 1294 | 168 | 20 | 30804502 |
| Pubmed | DOCK10 MFAP3L PLEKHH1 ZBED4 MEGF9 STARD9 RABGAP1L MAST1 KATNIP SLC39A14 SENP7 | 5.15e-06 | 407 | 168 | 11 | 12693553 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 5.87e-06 | 92 | 168 | 6 | 15840729 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A TRPM4 FLNC RIN3 KALRN BICRA DDX56 HUWE1 REV3L MYOF VAC14 DST CELSR2 ZBED4 NBEAL2 TANC1 FGFR2 CABIN1 | 7.40e-06 | 1105 | 168 | 18 | 35748872 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RGPD4 RANBP2 RGPD8 SFSWAP CALU CARS1 DDX56 RAB11FIP1 TBC1D8B RBMX2 RGPD3 MTREX RPL5 NXF1 | 8.70e-06 | 701 | 168 | 14 | 30196744 |
| Pubmed | 9.10e-06 | 9 | 168 | 3 | 19762425 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EFL1 RANBP2 ILF3 POLR1C HUWE1 CBS NUP35 DPH6 PDE12 RGPD3 MTREX RPL5 NXF1 RHOT1 | 9.13e-06 | 704 | 168 | 14 | 29955894 |
| Pubmed | SETD1A PPP2R2D KDM5C SPG11 TRANK1 DST NBEAL2 MDC1 MED12L AKAP11 CEP126 MTREX | 1.12e-05 | 529 | 168 | 12 | 14621295 | |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 1.26e-05 | 105 | 168 | 6 | 19156129 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | IPO5 EOGT PPP2R2D CALU POLR1C PTPN22 CBS MOSPD1 PPP2R2B PGRMC2 NT5C2 GOLIM4 RPL5 CLUH RHOT1 RPAP2 | 1.27e-05 | 931 | 168 | 16 | 27432908 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TRPM4 CALU BICRA SPG11 HUWE1 LMBRD2 MFAP3L MYOF CELSR2 RABGAP1L C6orf120 AHR GOLIM4 TYW1 SLC39A14 KYNU CDH17 | 1.66e-05 | 1061 | 168 | 17 | 33845483 |
| Pubmed | IPO5 FLNC RANBP2 PSMD2 DDX56 HUWE1 DST MDC1 MTREX ZNF512 RPL5 CLUH NXF1 | 1.90e-05 | 653 | 168 | 13 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO5 RANBP2 ILF3 CALU CARS1 PSMD2 DDX56 HUWE1 CBS NUP35 PDE12 DDX50 STARD9 MDC1 MTREX ZNF512 TALDO1 RPL5 CLUH NXF1 | 1.97e-05 | 1425 | 168 | 20 | 30948266 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLNC RANBP2 RELN ILF3 SFSWAP KALRN APC DDX56 DST DDX50 ZBED4 RBMX2 VCAN PGRMC2 PCDH15 RPL5 NXF1 | 2.13e-05 | 1082 | 168 | 17 | 38697112 |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36241614 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15609093 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 37781044 | ||
| Pubmed | DCC constrains tumour progression via its dependence receptor activity. | 2.32e-05 | 2 | 168 | 2 | 22158121 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17960519 | ||
| Pubmed | Abnormal corneal endothelial maturation in collagen XII and XIV null mice. | 2.32e-05 | 2 | 168 | 2 | 23599329 | |
| Pubmed | Activation of HIF-1α does not increase intestinal tumorigenesis. | 2.32e-05 | 2 | 168 | 2 | 24875099 | |
| Pubmed | Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer. | 2.32e-05 | 2 | 168 | 2 | 28169277 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 12719380 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32291851 | ||
| Pubmed | Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. | 2.32e-05 | 2 | 168 | 2 | 20844082 | |
| Pubmed | 3.06e-05 | 13 | 168 | 3 | 31001083 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 3.11e-05 | 182 | 168 | 7 | 31067453 | |
| Pubmed | EPC2 SFSWAP CALU BICRA KDM5C NTAQ1 MECOM DDX56 REV3L RAB11FIP1 TAF9B BRD7 AHR TANC1 RHOT1 SENP7 RPAP2 | 3.14e-05 | 1116 | 168 | 17 | 31753913 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.35e-05 | 410 | 168 | 10 | 26949251 | |
| Pubmed | Differential gene expression in migratory streams of cortical interneurons. | 3.88e-05 | 14 | 168 | 3 | 22103416 | |
| Pubmed | Protein interaction discovery using parallel analysis of translated ORFs (PLATO). | 3.93e-05 | 78 | 168 | 5 | 23503679 | |
| Pubmed | 3.94e-05 | 418 | 168 | 10 | 34709266 | ||
| Pubmed | TRPM4 RANBP2 SFSWAP POLR1C APC DDX56 RAB11FIP1 NUP35 MYOF HABP4 DST DDX50 RBMX2 RGPD3 MDC1 BRD7 GOLIM4 TANC1 MTREX NXF1 | 3.95e-05 | 1497 | 168 | 20 | 31527615 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IPO5 FLNC RANBP2 ILF3 PSMD2 DDX56 HUWE1 NUP35 CEP350 DST DDX50 PGRMC2 MDC1 MTREX RPL5 NXF1 | 4.02e-05 | 1024 | 168 | 16 | 24711643 |
| Pubmed | 4.19e-05 | 40 | 168 | 4 | 37516964 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 4.83e-05 | 195 | 168 | 7 | 17110338 | |
| Pubmed | 6.29e-05 | 86 | 168 | 5 | 37253089 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TTC21A HUWE1 REV3L PARP4 RNF123 PDE12 DST ZBED4 AHR PBX2 NXF1 ELP4 ADIPOR2 | 6.48e-05 | 736 | 168 | 13 | 29676528 |
| Pubmed | RGPD4 FLNC RANBP2 ILF3 RGPD8 PPP2R2D CALU MUC16 PSMD2 PPP2R2B DST RGPD3 RPL5 RGPD5 | 6.61e-05 | 844 | 168 | 14 | 25963833 | |
| Pubmed | EPC2 SETD1A CALU BICRA MECOM PSMD2 DDX56 DST DDX50 TAF9B MDC1 BRD7 MARF1 NT5C2 PBX2 ZNF512 CABIN1 NXF1 RHOT1 | 6.64e-05 | 1429 | 168 | 19 | 35140242 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 7545161 | ||
| Pubmed | E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. | 6.94e-05 | 3 | 168 | 2 | 28137882 | |
| Pubmed | Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis. | 6.94e-05 | 3 | 168 | 2 | 31043706 | |
| Interaction | SIRT6 interactions | SETD1A RANBP2 HIF1A ILF3 RGPD8 APC PSMD2 DDX56 ZDBF2 HUWE1 NUP35 DDX50 CELSR2 MDC1 BRD7 AHR MTREX RPL5 NXF1 RGPD5 RPAP2 | 6.60e-08 | 628 | 168 | 21 | int:SIRT6 |
| Interaction | RGPD1 interactions | 1.58e-07 | 49 | 168 | 7 | int:RGPD1 | |
| Interaction | IER2 interactions | 5.76e-07 | 37 | 168 | 6 | int:IER2 | |
| Interaction | RGPD4 interactions | 8.90e-07 | 22 | 168 | 5 | int:RGPD4 | |
| Interaction | RGPD5 interactions | 1.40e-06 | 96 | 168 | 8 | int:RGPD5 | |
| Interaction | RGPD3 interactions | 2.48e-06 | 47 | 168 | 6 | int:RGPD3 | |
| Interaction | RGPD2 interactions | 2.64e-06 | 27 | 168 | 5 | int:RGPD2 | |
| Interaction | TNFAIP1 interactions | 2.78e-06 | 74 | 168 | 7 | int:TNFAIP1 | |
| Interaction | KLF6 interactions | 1.47e-05 | 95 | 168 | 7 | int:KLF6 | |
| Interaction | MYBPC2 interactions | 3.54e-05 | 45 | 168 | 5 | int:MYBPC2 | |
| Interaction | AKIRIN2 interactions | 3.56e-05 | 74 | 168 | 6 | int:AKIRIN2 | |
| Interaction | RGPD8 interactions | 3.56e-05 | 74 | 168 | 6 | int:RGPD8 | |
| Interaction | ZNF207 interactions | 4.05e-05 | 111 | 168 | 7 | int:ZNF207 | |
| Interaction | ABCF2 interactions | 6.66e-05 | 209 | 168 | 9 | int:ABCF2 | |
| Interaction | NUP43 interactions | SETD1A RANBP2 RGPD8 KDM5C APC ZDBF2 CCDC168 DST TAF9B RBMX2 MDC1 MARF1 ZNF512 RPL5 ELP4 RGPD5 | 7.11e-05 | 625 | 168 | 16 | int:NUP43 |
| Interaction | PTGES3 interactions | DPP4 RANBP2 RIN3 HIF1A CALU POLR1C ARMCX5 PLEKHH1 C5orf34 NT5C2 AHR TANC1 ADIPOR2 | 7.93e-05 | 437 | 168 | 13 | int:PTGES3 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.58e-07 | 115 | 114 | 8 | 769 | |
| GeneFamily | Fibronectin type III domain containing | 6.94e-05 | 160 | 114 | 7 | 555 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 1.05e-04 | 15 | 114 | 3 | 696 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 6.22e-06 | 71 | 167 | 6 | M9544 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RANBP2 RGPD8 SFSWAP KDM5C ZDBF2 ARMCX5 HABP4 PDE12 MIS12 TAF9B PGRMC2 BRD7 MARF1 TACC1 RGPD5 PHACTR1 | 7.83e-06 | 680 | 167 | 16 | M41089 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CADM3 RELN APC REV3L DCC CPNE5 NDST3 PPP2R2B PPP2R2C MEGF9 SLC24A2 VCAN RABGAP1L RASGEF1B FUT9 MAST1 CEP126 ZMAT1 HYDIN EPHA3 PDZRN4 | 8.02e-06 | 1106 | 167 | 21 | M39071 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | FLNC RELN EOGT COL12A1 CALU DOCK10 ASPHD2 PPP2R2B DST VCAN GOLIM4 COL14A1 TACC1 | 1.31e-05 | 479 | 167 | 13 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | FLNC RELN EOGT COL12A1 CALU DOCK10 ASPHD2 PPP2R2B DST VCAN GOLIM4 COL14A1 TACC1 | 1.43e-05 | 483 | 167 | 13 | MM1082 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 2.02e-05 | 87 | 167 | 6 | MM851 | |
| Coexpression | GSE14308_TH1_VS_NATURAL_TREG_DN | 4.33e-05 | 199 | 167 | 8 | M3381 | |
| Coexpression | GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP | 4.49e-05 | 200 | 167 | 8 | M7064 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 4.49e-05 | 200 | 167 | 8 | M9922 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 4.49e-05 | 200 | 167 | 8 | M6021 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 5.63e-05 | 33 | 167 | 4 | MM477 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RELN KALRN DCC MFAP3L PPP2R2B DST TAF9B RABGAP1L C6orf120 ASPA RASGEF1B MARF1 FUT9 OSBPL9 AHR FGFR2 CABIN1 ZMAT1 PDZRN4 | 8.15e-05 | 1102 | 167 | 19 | M2369 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 8.49e-05 | 219 | 167 | 8 | M41199 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RELN KALRN DCC MFAP3L PPP2R2B DST TAF9B RABGAP1L C6orf120 ASPA RASGEF1B MARF1 FUT9 OSBPL9 AHR FGFR2 CABIN1 ZMAT1 PDZRN4 | 1.05e-04 | 1124 | 167 | 19 | MM1070 |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN | 1.09e-04 | 169 | 167 | 7 | M6504 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 6.51e-06 | 166 | 166 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.66e-05 | 69 | 166 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | FLNC COL12A1 MUC16 TEX15 REV3L CEP350 MYOF SLC7A2 TRANK1 FRMD6 VCAN RABGAP1L COL14A1 AKAP11 FGFR2 SPIDR ZMAT1 EPHA3 | 2.07e-05 | 740 | 166 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 2.30e-05 | 149 | 166 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DPP4 FLNC ADAM19 KALRN CALU DOCK10 MUC16 SKA2 ZDBF2 TEX15 REV3L CEP350 MYOF SLC7A2 TRANK1 VCAN COL14A1 SPIDR ZMAT1 | 2.65e-05 | 827 | 166 | 19 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | CADM3 MECOM DCC TBC1D8B CEP350 PLEKHH1 HABP4 RNF123 DST CELSR2 MEGF9 NT5C2 FUT9 MAST1 SENP7 EPHA3 PHACTR1 | 2.67e-05 | 683 | 166 | 17 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CADM3 EPC2 MECOM ZDBF2 DCC TBC1D8B CEP350 HABP4 DST MEGF9 NT5C2 FUT9 MAST1 FGFR2 SENP7 EPHA3 PHACTR1 | 2.92e-05 | 688 | 166 | 17 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | FLNC NTAQ1 DOCK10 MUC16 ZDBF2 REV3L TBC1D8B MYOF TRANK1 VCAN RASGEF1B COL14A1 | 3.07e-05 | 364 | 166 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | FLNC ADAM19 NTAQ1 DOCK10 MUC16 SKA2 ZDBF2 REV3L TBC1D8B MYOF SLC7A2 TRANK1 STARD9 VCAN RASGEF1B COL14A1 ZMAT1 EPHA3 | 3.38e-05 | 768 | 166 | 18 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | PNLIPRP1 SYT17 CA13 MFAP3L CEP350 PLEKHH1 MYOF PARP4 PPP2R2B PDE12 DST NBEAL2 RABGAP1L FUT9 AHR FGFR2 NOCT CDH17 | 4.13e-05 | 780 | 166 | 18 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | DPP4 RELN ILF3 UNCX SYT17 APC MECOM HUWE1 REV3L MFAP3L CEP350 PLEKHH1 DST SLC12A1 CELSR2 MED12L COL14A1 PDZRN4 | 5.28e-05 | 795 | 166 | 18 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_100 | 6.24e-05 | 87 | 166 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | CADM3 MECOM DCC TBC1D8B CEP350 HABP4 RNF123 DST MEGF9 NT5C2 FUT9 MAST1 FGFR2 ZMAT1 SENP7 EPHA3 PHACTR1 | 7.58e-05 | 743 | 166 | 17 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | DPP4 ILF3 UNCX SYT17 APC HUWE1 REV3L MFAP3L CEP350 SLC12A1 MED12L PDZRN4 | 7.98e-05 | 402 | 166 | 12 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | CADM3 MECOM DCC CEP350 HABP4 RNF123 DST CELSR2 MEGF9 NT5C2 FUT9 MED12L MAST1 FGFR2 SENP7 EPHA3 PHACTR1 | 8.09e-05 | 747 | 166 | 17 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | FLNC ADAM19 KALRN DOCK10 MUC16 SKA2 ZDBF2 MYOF SLC7A2 VCAN COL14A1 SPIDR | 1.15e-04 | 418 | 166 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | EPC2 FLNC PNLIPRP1 KALRN DOCK10 MUC16 CA13 SKA2 ZDBF2 TEX15 REV3L MYOF TRANK1 RBMX2 VCAN RASGEF1B COL14A1 SPIDR | 1.21e-04 | 849 | 166 | 18 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | FLNC COL12A1 PNLIPRP1 DOCK10 MUC16 SKA2 ZDBF2 TEX15 SLC7A2 VCAN SPIDR ZMAT1 | 1.29e-04 | 423 | 166 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 1.48e-04 | 194 | 166 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | CADM3 MECOM DCC TBC1D8B CEP350 HABP4 RNF123 DST MEGF9 NT5C2 FUT9 MAST1 FGFR2 SENP7 EPHA3 PHACTR1 | 1.79e-04 | 722 | 166 | 16 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#4 | 1.80e-04 | 67 | 166 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | CADM3 MECOM DCC TBC1D8B CEP350 HABP4 RNF123 DST MEGF9 NT5C2 FUT9 MED12L MAST1 SENP7 EPHA3 PHACTR1 | 2.02e-04 | 730 | 166 | 16 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | CADM3 MECOM DCC TBC1D8B CEP350 HABP4 DST CELSR2 MEGF9 STARD9 NT5C2 FUT9 MAST1 SENP7 EPHA3 PHACTR1 | 2.09e-04 | 732 | 166 | 16 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | CADM3 MECOM DCC TBC1D8B CEP350 HABP4 DST MEGF9 NT5C2 FUT9 MAST1 FGFR2 SENP7 EPHA3 PHACTR1 | 2.12e-04 | 658 | 166 | 15 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | CADM3 EPC2 MECOM ZDBF2 DCC TBC1D8B CEP350 PLEKHH1 HABP4 DST TAF9B NT5C2 FUT9 MAST1 TACC1 SENP7 EPHA3 PHACTR1 | 2.26e-04 | 893 | 166 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.54e-04 | 210 | 166 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | CADM3 MECOM DCC TBC1D8B CEP350 HABP4 DST MEGF9 NT5C2 FUT9 MAST1 FGFR2 NXF1 SENP7 EPHA3 PHACTR1 | 2.62e-04 | 747 | 166 | 16 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RANBP2 ZDBF2 CEP350 HABP4 CELSR2 MEGF9 FUT9 MED12L EPHA3 PHACTR1 | 2.68e-04 | 328 | 166 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DPP4 FLNC COL12A1 PNLIPRP1 KALRN CALU DOCK10 MUC16 SKA2 ZDBF2 TEX15 CEP350 SLC7A2 VCAN COL14A1 SPIDR ZMAT1 | 2.86e-04 | 831 | 166 | 17 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | FLNC RELN ADAM19 BICRA ZDBF2 NR6A1 ARMCX5 GGTA1 PLEKHH1 DST CELSR2 ZBED4 MDC1 BRD7 FUT9 TYW1 FGFR2 SLC39A14 RPL5 | 2.94e-04 | 994 | 166 | 19 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 3.02e-04 | 163 | 166 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 | TRPM4 EFL1 FOXN2 EPHA6 NR6A1 SH3D21 MFAP3L PLEKHH1 MYOF PARP4 PPP2R2B DST FRMD6 MEGF9 NBEAL2 RASGEF1B NT5C2 AHR TACC1 FGFR2 RPL5 CLUH ADIPOR2 | 3.05e-04 | 1337 | 166 | 23 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | DPP4 EOGT UNCX SYT17 DOCK10 CA13 ZDBF2 HUWE1 GGTA1 TARS3 CELSR2 VCAN MED12L AHR GOLIM4 SENP7 EPHA3 | 3.07e-04 | 836 | 166 | 17 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.25e-04 | 165 | 166 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 3.34e-04 | 118 | 166 | 6 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | CADM3 EPC2 MECOM DCC TBC1D8B CEP350 DST NT5C2 FUT9 MAST1 CEP126 SENP7 EPHA3 PHACTR1 | 3.44e-04 | 614 | 166 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | COL12A1 PNLIPRP1 CALU TEX15 REV3L SH3D21 SLC7A2 DST FRMD6 FGFR2 SPIDR | 3.49e-04 | 404 | 166 | 11 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_200 | 3.62e-04 | 168 | 166 | 7 | gudmap_kidney_e15.5_Podocyte_MafB_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.62e-04 | 168 | 166 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_100 | 3.66e-04 | 78 | 166 | 5 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | ILF3 PNLIPRP1 KALRN SYT17 APC HUWE1 REV3L CEP350 DST VCAN EPHA3 | 3.72e-04 | 407 | 166 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | FLNC ADAM19 NTAQ1 MUC16 SKA2 ZDBF2 REV3L TBC1D8B CEP350 MYOF SLC7A2 TRANK1 VCAN RASGEF1B COL14A1 EPHA3 | 3.82e-04 | 773 | 166 | 16 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | DPP4 UNCX SYT17 APC MECOM HUWE1 REV3L MFAP3L CEP350 SLC12A1 CELSR2 ZBED4 NBEAL2 MED12L FGFR2 PHACTR1 | 3.87e-04 | 774 | 166 | 16 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.18e-04 | 45 | 166 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.32e-04 | 173 | 166 | 7 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_100 | 4.36e-04 | 81 | 166 | 5 | gudmap_developingKidney_e15.5_anlage of loop of Henle_100 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_100 | 4.62e-04 | 82 | 166 | 5 | gudmap_kidney_e15.5_Podocyte_MafB_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | COL12A1 PNLIPRP1 CALU MUC16 TEX15 REV3L SH3D21 SLC7A2 TRANK1 DST FRMD6 STARD9 FGFR2 SPIDR PBX2 ZMAT1 | 4.91e-04 | 791 | 166 | 16 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | FLNC NTAQ1 MUC16 ZDBF2 MYOF TRANK1 VCAN RASGEF1B COL14A1 EPHA3 | 5.10e-04 | 356 | 166 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | CADM3 MECOM DCC TBC1D8B CEP350 HABP4 RNF123 DST MEGF9 NT5C2 FUT9 MAST1 SENP7 EPHA3 PHACTR1 | 5.54e-04 | 721 | 166 | 15 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | CADM3 DOCK10 MECOM NR6A1 DCC TBC1D8B SH3D21 MYOF SLC7A2 KCNJ2 PCDH15 AHR MAST1 COL14A1 ZMAT1 SENP7 EPHA3 PHACTR1 | 5.82e-04 | 967 | 166 | 18 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500 | COL12A1 PNLIPRP1 DOCK10 TEX15 REV3L SLC7A2 TRANK1 DST VCAN RASGEF1B SPIDR | 6.11e-04 | 432 | 166 | 11 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | DOCK10 MECOM NR6A1 RAB11FIP1 PLEKHH1 MYOF SLC7A2 CELSR2 KCNJ2 NBEAL2 RABGAP1L PCDH15 FUT9 MAST1 COL14A1 SENP7 EPHA3 PHACTR1 | 6.26e-04 | 973 | 166 | 18 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RANBP2 ZDBF2 TBC1D8B CEP350 HABP4 DST CELSR2 MEGF9 STARD9 NT5C2 FUT9 MED12L EPHA3 PHACTR1 | 6.43e-04 | 654 | 166 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | IPO5 FOXN2 DOCK10 MECOM NR6A1 RAB11FIP1 SH3D21 MYOF SLC7A2 CELSR2 PCDH15 FUT9 AHR COL14A1 FGFR2 SENP7 EPHA3 PHACTR1 | 6.49e-04 | 976 | 166 | 18 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | DOCK10 MECOM TEX15 RAB11FIP1 PLEKHH1 MYOF SLC7A2 CELSR2 FRMD6 PCDH15 FUT9 MED12L MAST1 COL14A1 SDK1 SENP7 EPHA3 PHACTR1 | 7.13e-04 | 984 | 166 | 18 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PSMD2 NR6A1 TEX15 HUWE1 CPNE5 TARS3 TRANK1 TAF9B RBMX2 RABGAP1L MDC1 SYT14 USP32 MED12L AKAP11 TRMT5 | 7.22e-04 | 820 | 166 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | FLNC DOCK10 MUC16 SKA2 REV3L MYOF TRANK1 VCAN RASGEF1B COL14A1 | 7.30e-04 | 373 | 166 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 7.82e-04 | 92 | 166 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.86e-04 | 311 | 166 | 9 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | ILF3 SYT17 APC HUWE1 REV3L MFAP3L CEP350 SLC12A1 MED12L PDZRN4 | 8.24e-04 | 379 | 166 | 10 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#3_top-relative-expression-ranked_100 | 8.93e-04 | 6 | 166 | 2 | gudmap_kidney_e10.5_UretericTip_HoxB7_k3_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | FLNC COL12A1 MUC16 TEX15 MYOF SLC7A2 TRANK1 VCAN FGFR2 SPIDR | 9.85e-04 | 388 | 166 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.01e-03 | 259 | 166 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | DPP4 SYT17 APC HUWE1 REV3L MFAP3L CEP350 SLC12A1 MED12L FGFR2 | 1.02e-03 | 390 | 166 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | IPO5 SETD1A FLNC RELN CA13 ZDBF2 NR6A1 ARMCX5 BTBD9 MOSPD1 NUP35 VAC14 PDE12 CELSR2 ZBED4 RBMX2 SYT14 BRD7 CEP126 SLC39A14 MTREX TRMT5 | 1.05e-03 | 1371 | 166 | 22 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_500 | 1.06e-03 | 147 | 166 | 6 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_500 | |
| CoexpressionAtlas | B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21.35+, Spleen, avg-1 | 1.10e-03 | 58 | 166 | 4 | GSM538210_100 | |
| CoexpressionAtlas | B cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21/35+, Spleen, avg-2 | 1.10e-03 | 58 | 166 | 4 | GSM538211_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.14e-03 | 149 | 166 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.19e-03 | 330 | 166 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.24e-03 | 207 | 166 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 184 | 168 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 184 | 168 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-08 | 184 | 168 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-08 | 189 | 168 | 9 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.68e-08 | 190 | 168 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.90e-08 | 191 | 168 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-08 | 192 | 168 | 9 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DPP4 MECOM BTBD9 RAB11FIP1 CELSR2 MEGF9 NBEAL2 FGFR2 PHACTR1 | 5.12e-08 | 192 | 168 | 9 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.97e-08 | 199 | 168 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.80e-07 | 170 | 168 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-07 | 180 | 168 | 8 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 4.91e-07 | 183 | 168 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 185 | 168 | 8 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-07 | 187 | 168 | 8 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.78e-07 | 187 | 168 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-07 | 187 | 168 | 8 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-07 | 189 | 168 | 8 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.26e-07 | 189 | 168 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.52e-07 | 190 | 168 | 8 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 160 | 168 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 160 | 168 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-06 | 172 | 168 | 7 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 4.16e-06 | 172 | 168 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.32e-06 | 173 | 168 | 7 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-06 | 175 | 168 | 7 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-31|World / Primary Cells by Cluster | 4.66e-06 | 175 | 168 | 7 | 491508bf9e8a09b057d5711cc23dd91324e6a806 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 4.84e-06 | 176 | 168 | 7 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 5.21e-06 | 178 | 168 | 7 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.40e-06 | 179 | 168 | 7 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 5.40e-06 | 179 | 168 | 7 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-06 | 179 | 168 | 7 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 181 | 168 | 7 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 182 | 168 | 7 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 6.25e-06 | 183 | 168 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 183 | 168 | 7 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 185 | 168 | 7 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 186 | 168 | 7 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 186 | 168 | 7 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.95e-06 | 186 | 168 | 7 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.95e-06 | 186 | 168 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 186 | 168 | 7 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 7.20e-06 | 187 | 168 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.45e-06 | 188 | 168 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.45e-06 | 188 | 168 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.71e-06 | 189 | 168 | 7 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-06 | 189 | 168 | 7 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-06 | 189 | 168 | 7 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.71e-06 | 189 | 168 | 7 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 8.26e-06 | 191 | 168 | 7 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-06 | 191 | 168 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 8.55e-06 | 192 | 168 | 7 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.14e-06 | 194 | 168 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.14e-06 | 194 | 168 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.14e-06 | 194 | 168 | 7 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.46e-06 | 195 | 168 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.46e-06 | 195 | 168 | 7 | 9c6bed8414633813e1655bbeaab682fb296958a9 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 195 | 168 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 195 | 168 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-05 | 130 | 168 | 6 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 197 | 168 | 7 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.01e-05 | 197 | 168 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 198 | 168 | 7 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 168 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 168 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 198 | 168 | 7 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 168 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 199 | 168 | 7 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-05 | 199 | 168 | 7 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-05 | 200 | 168 | 7 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.11e-05 | 200 | 168 | 7 | 0f23e72649a274043bf23e0952a9b5707c516acf | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.11e-05 | 200 | 168 | 7 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.30e-05 | 136 | 168 | 6 | 9d7080f695de4ef183e3dbdc18ba464a3b8e3469 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.19e-05 | 149 | 168 | 6 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | Adult-Immune-dendritic_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.64e-05 | 154 | 168 | 6 | 64a4686586d08b1e9632dde917b472ac660de2d3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.15e-05 | 159 | 168 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.27e-05 | 160 | 168 | 6 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-05 | 162 | 168 | 6 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 3.88e-05 | 165 | 168 | 6 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-05 | 166 | 168 | 6 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 4.29e-05 | 168 | 168 | 6 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.29e-05 | 168 | 168 | 6 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 168 | 168 | 6 | 6c7b490b6c844d0ea4c07edfc24c02284f9533c4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.44e-05 | 169 | 168 | 6 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.46e-05 | 103 | 168 | 5 | 780a94c27ac3eb138a9f284251ae094d3e97ce71 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 170 | 168 | 6 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 170 | 168 | 6 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-05 | 170 | 168 | 6 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 4.74e-05 | 171 | 168 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 5.22e-05 | 174 | 168 | 6 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-05 | 174 | 168 | 6 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 5.22e-05 | 174 | 168 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 174 | 168 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.22e-05 | 174 | 168 | 6 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-05 | 174 | 168 | 6 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 175 | 168 | 6 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.56e-05 | 176 | 168 | 6 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 176 | 168 | 6 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 5.56e-05 | 176 | 168 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | PRUNE2 FOXN2 RIN3 BICRA SYT17 CHRNB3 MFAP3L PPP2R2B COL14A1 FUT3 | 1.87e-06 | 194 | 168 | 10 | 6741_UP |
| Drug | Clorgyline | 4.54e-06 | 168 | 168 | 9 | ctd:D003010 | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 5528_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 1.64e-05 | 197 | 168 | 9 | 2712_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 2197_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.70e-05 | 198 | 168 | 9 | 5615_UP | |
| Disease | alcohol consumption measurement | SETD1A DPP4 FOXN2 RELN COL12A1 UNCX CALU PSMD2 NR6A1 DCC CPNE5 NDST3 MLIP DDX50 MEGF9 RABGAP1L SYT14 AKAP11 SDK1 SENP7 EPHA3 PHACTR1 | 1.06e-06 | 1242 | 160 | 22 | EFO_0007878 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.32e-05 | 12 | 160 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | EPHA6 PSMD2 REV3L ZP3 CBS PARP4 MLIP CELSR2 RABGAP1L PCDH15 NOCT SLC51A KYNU PHACTR1 PDZRN4 | 2.05e-04 | 945 | 160 | 15 | EFO_0005653 |
| Disease | Splenomegaly | 2.23e-04 | 22 | 160 | 3 | C0038002 | |
| Disease | reaction time measurement | DPP4 APC MECOM SKA2 DCC PPP2R2B PDE12 MIS12 RABGAP1L RASGEF1B PHACTR1 PDZRN4 | 2.63e-04 | 658 | 160 | 12 | EFO_0008393 |
| Disease | Bipolar Disorder | RELN HIF1A CBS CHRNB3 NDST3 PPP2R2C TRANK1 STARD9 FGFR2 CDH17 | 2.92e-04 | 477 | 160 | 10 | C0005586 |
| Disease | physical activity measurement | 3.97e-04 | 245 | 160 | 7 | EFO_0008002 | |
| Disease | Inflammatory Myofibroblastic Tumor | 4.32e-04 | 6 | 160 | 2 | C0334121 | |
| Disease | smoking behavior | 5.72e-04 | 341 | 160 | 8 | EFO_0004318 | |
| Disease | insomnia measurement | 7.33e-04 | 443 | 160 | 9 | EFO_0007876 | |
| Disease | glucagon-like peptide-1 measurement, glucose tolerance test | 8.01e-04 | 8 | 160 | 2 | EFO_0004307, EFO_0008465 | |
| Disease | ovarian cancer (implicated_via_orthology) | 8.01e-04 | 8 | 160 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | neonatal abstinence syndrome | 8.28e-04 | 77 | 160 | 4 | EFO_0005799 | |
| Disease | Depression, Bipolar | 9.12e-04 | 79 | 160 | 4 | C0005587 | |
| Disease | skin pigmentation measurement | 9.25e-04 | 137 | 160 | 5 | EFO_0007009 | |
| Disease | Silicosis | 1.03e-03 | 9 | 160 | 2 | C0037116 | |
| Disease | Gastrointestinal Hemorrhage | 1.03e-03 | 9 | 160 | 2 | C0017181 | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | cortical surface area measurement | DPP4 DCHS2 RELN RIN3 DOCK10 APC MECOM STN1 VCAN MDC1 RASGEF1B NT5C2 TACC1 FGFR2 RHOT1 EPHA3 PDZRN4 | 1.05e-03 | 1345 | 160 | 17 | EFO_0010736 |
| Disease | lysine measurement | 1.06e-03 | 37 | 160 | 3 | EFO_0005002 | |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0801544 | |
| Disease | glucagon-like peptide-1 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0008465 | |
| Disease | Gastric cancer | 1.56e-03 | 11 | 160 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 1.56e-03 | 11 | 160 | 2 | cv:C0038356 | |
| Disease | Complications of Diabetes Mellitus | 1.56e-03 | 11 | 160 | 2 | C0342257 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 1.56e-03 | 11 | 160 | 2 | C1335302 | |
| Disease | colon cancer (implicated_via_orthology) | 1.56e-03 | 11 | 160 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | GASTRIC CANCER | 1.56e-03 | 11 | 160 | 2 | 613659 | |
| Disease | brain volume measurement | 1.58e-03 | 595 | 160 | 10 | EFO_0006930 | |
| Disease | fibromuscular dysplasia | 1.76e-03 | 44 | 160 | 3 | EFO_1000938 | |
| Disease | brain disease (is_implicated_in) | 1.86e-03 | 12 | 160 | 2 | DOID:936 (is_implicated_in) | |
| Disease | cognitive function measurement | EFL1 PPP2R2D KALRN CALU PSMD2 ZDBF2 DCC LMBRD2 ZP3 VAC14 RABGAP1L MED12L MAST1 TACC1 SDK1 HYDIN CDH17 | 2.08e-03 | 1434 | 160 | 17 | EFO_0008354 |
| Disease | susceptibility to chickenpox measurement | 2.13e-03 | 47 | 160 | 3 | EFO_0008400 | |
| Disease | FVC change measurement, response to placebo | 2.19e-03 | 13 | 160 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | complement factor H-related protein 3 measurement | 2.33e-03 | 169 | 160 | 5 | EFO_0600056 | |
| Disease | C-reactive protein measurement | CADM3 RPGRIP1 DCHS2 ADAM19 PPP2R2D SKA2 SPG11 CCDC168 ZNF112 TRANK1 CELSR2 PCDH15 SLC51A ZNF512 EPHA3 | 2.42e-03 | 1206 | 160 | 15 | EFO_0004458 |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 2.55e-03 | 14 | 160 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | Mental Depression | 2.70e-03 | 254 | 160 | 6 | C0011570 | |
| Disease | asthma | CADM3 DPP4 RIN3 ADAM19 MUC16 MECOM SLC24A2 USP32 PBX2 KYNU SENP7 | 2.73e-03 | 751 | 160 | 11 | MONDO_0004979 |
| Disease | platelet component distribution width | PRUNE2 RIN3 KALRN DOCK10 SIGLEC5 MECOM PSMD2 NUP35 HABP4 TRANK1 KYNU | 2.84e-03 | 755 | 160 | 11 | EFO_0007984 |
| Disease | cerebellar volume measurement | 2.85e-03 | 52 | 160 | 3 | EFO_0020864 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.93e-03 | 15 | 160 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Intellectual Disability | 3.15e-03 | 447 | 160 | 8 | C3714756 | |
| Disease | chronotype measurement | EPC2 RELN ILF3 PPP2R2D BTBD9 PPP2R2B RNF123 RABGAP1L PCDH15 NT5C2 NOCT PHACTR1 | 3.22e-03 | 882 | 160 | 12 | EFO_0008328 |
| Disease | Benign neoplasm of stomach | 3.77e-03 | 17 | 160 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.77e-03 | 17 | 160 | 2 | C0496905 | |
| Disease | Multiple congenital anomalies | 3.77e-03 | 17 | 160 | 2 | C0000772 | |
| Disease | Carcinoma in situ of stomach | 3.77e-03 | 17 | 160 | 2 | C0154060 | |
| Disease | intelligence, self reported educational attainment | 3.84e-03 | 117 | 160 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | velopharyngeal dysfunction | 4.46e-03 | 122 | 160 | 4 | EFO_0009336 | |
| Disease | executive function measurement | 4.56e-03 | 376 | 160 | 7 | EFO_0009332 | |
| Disease | longevity | 4.65e-03 | 284 | 160 | 6 | EFO_0004300 | |
| Disease | Usual Interstitial Pneumonia | 4.70e-03 | 19 | 160 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.70e-03 | 19 | 160 | 2 | C4721508 | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.70e-03 | 19 | 160 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | neuroimaging measurement, brain volume measurement | 4.81e-03 | 286 | 160 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | Alzheimer disease, polygenic risk score | 4.83e-03 | 586 | 160 | 9 | EFO_0030082, MONDO_0004975 | |
| Disease | angina pectoris | 4.85e-03 | 125 | 160 | 4 | EFO_0003913 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 5.21e-03 | 20 | 160 | 2 | C4721952 | |
| Disease | Malignant Neoplasms | 5.28e-03 | 128 | 160 | 4 | C0006826 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.42e-03 | 206 | 160 | 5 | C0152013 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KASYHFSPEELDENT | 261 | O75410 | |
| TDLHGISQEFPYKSE | 676 | P35869 | |
| GEHPKFTNYSFDVEE | 486 | Q5NDL2 | |
| KQYDFHSSDEDEFPQ | 366 | Q52LR7 | |
| DHVDRYSSPEKEESQ | 351 | Q05901 | |
| STFQSHEPEFDYLKS | 71 | Q00005 | |
| STFQSHEPEFDYLKS | 71 | Q9Y2T4 | |
| NIEATFKPSSEEYLH | 2871 | P13611 | |
| SASSLHPSFDDYELQ | 81 | Q7Z4R8 | |
| ELYKHLDSSSNERPD | 401 | P49902 | |
| APHYDSTFANISKDD | 411 | Q9NPI1 | |
| EKNEQLFAPSYTETH | 81 | Q9H013 | |
| SATFEHLVYKIDSDD | 151 | O43506 | |
| HLEDKVSSVPDNYRT | 246 | Q7L8W6 | |
| EDTDDSHLYFSPEQG | 216 | Q7Z2Z2 | |
| STFQSHEPEFDYLKS | 81 | Q66LE6 | |
| FEHLEEEETSKPYND | 191 | Q9UKA4 | |
| ATKEEFTAFLHPEEY | 171 | O43852 | |
| APKDESLHSFLSADY | 36 | A6NK59 | |
| SDKYPSFVEAAHEPD | 126 | Q8N1Q1 | |
| AHDPDISDSLTYSFE | 1051 | Q9HCU4 | |
| TYLTHEAKGSDDAPD | 361 | Q8N126 | |
| YPDNVHAAAEEKSAI | 621 | P52569 | |
| ESSEEPKSGESYIHQ | 381 | Q6P1M9 | |
| YDPLFIVSSEKDHTQ | 41 | Q7Z4T9 | |
| NSKDAAYSFAENPEH | 451 | Q8IYR0 | |
| PFSKYLEDNSDLFSE | 356 | Q5VWP3 | |
| EKSANYFHSEEAPKR | 666 | O95803 | |
| DAYKTEDSDDIHFEP | 2001 | P49792 | |
| EHPEKSDKDSSSAYN | 726 | Q6ZMN7 | |
| KKSSEEHEYSDEAPQ | 56 | Q86V24 | |
| HVSNYRAPKDSEEID | 111 | Q9Y388 | |
| AYKTEDSDDIHFEPV | 1026 | Q99666 | |
| AYKTEDSDDIHFEPV | 1026 | O14715 | |
| KENFSYLESQPHDSC | 466 | Q9Y2R2 | |
| YDADEFHQSGSSPKR | 296 | Q96SU4 | |
| HEIDEDSPLYDLSKQ | 271 | P63252 | |
| KEYSNHSIFSPSLEE | 636 | Q03112 | |
| APEALFDRVYTHQSD | 671 | P21802 | |
| ERPATYKDTAHTEAA | 5401 | Q8WXI7 | |
| SEESHKPTEDSANVY | 1406 | P43146 | |
| SPDNSIEHSDYRSKL | 151 | P40425 | |
| AYLEATEPAVTHDKN | 386 | O75121 | |
| RSPVGENADEHYSKD | 636 | Q86YW9 | |
| EDSETQPFDTHLEAY | 761 | Q14676 | |
| KEEYPHSFLQESLET | 46 | A6NFK2 | |
| KFQPSTVHDYRQEED | 1956 | Q03001 | |
| SKESEVFYELAHQLP | 31 | Q16665 | |
| FDLNDTKLYVSPHDV | 501 | O60303 | |
| FIHVEDYNSPSELAK | 286 | Q9Y231 | |
| HSEKLKTYFEDNPRD | 456 | Q9NY93 | |
| KDDYEDDSHVFRKPA | 336 | Q5JVS0 | |
| PGSTHSYEFDAKLDV | 396 | P54315 | |
| KSYSEHDDERVNFPQ | 6 | Q9UBU9 | |
| LHEVKQEYSISPTDF | 531 | Q8IXI2 | |
| QHDISFYEALESDPL | 396 | Q6L8Q7 | |
| EPSEYTDEEDTKDHN | 206 | O15173 | |
| YEVSIKFNDEHIPDS | 2381 | Q14315 | |
| FPLVKDAYSHSSSEN | 1721 | O60229 | |
| PTELIFYADDQSTHK | 21 | Q9UJG1 | |
| KEDNISFSSYHDSIP | 556 | Q9H1U4 | |
| DEFGHSINDYSISPD | 96 | P27487 | |
| EYHPDASAQESFAVS | 131 | Q96H12 | |
| IKDFHPSDHTELEEY | 571 | Q9UKK3 | |
| PLHEDKEEAVQTFNY | 1001 | O00410 | |
| ASYESEGPENHIEKD | 446 | Q0VAM2 | |
| NALAAYHAPEEADKS | 1951 | Q7Z6Z7 | |
| EFIPHLESEDDTSYF | 661 | Q9Y2H9 | |
| YADDNSTKHEEKPQL | 31 | Q5R372 | |
| DDCSVFSHDLPSYIK | 3256 | P78509 | |
| DENDHAPEFIVSSYD | 1821 | Q6V1P9 | |
| KENVPHESDYEDSSC | 376 | Q9C0D0 | |
| DTKLYAPTHKEAEFQ | 301 | O00461 | |
| DHKVGYETFSSPDLD | 321 | Q86UW1 | |
| LSPEDHSFLEDLATY | 746 | Q8IUM7 | |
| TKDPELHLFLNDYTS | 436 | Q96QU1 | |
| LSDEDDLSAHNPLYK | 1516 | Q96QU1 | |
| DAYKTEDSDDIHFEP | 1026 | A6NKT7 | |
| KYFSLDLTHDEVPEF | 606 | Q96NE9 | |
| TPYFSRDAQKHDVEV | 176 | Q6ICH7 | |
| EVHYPNLSFETKELD | 1161 | Q4G0P3 | |
| QKELAASTSEDTHPY | 921 | Q9Y6J0 | |
| ASTSEDTHPYKEELE | 926 | Q9Y6J0 | |
| TLYSTVPEDAEHKAE | 91 | Q96BY6 | |
| IATDPDDTHAYNVAD | 1346 | Q99715 | |
| SFQDAYIPHNPDSKD | 521 | Q9P2H0 | |
| ASEPDSTHVYNVAEF | 306 | Q05707 | |
| AKHSSVYPTQEELEA | 16 | Q12906 | |
| DIIHESYKTDSEDNP | 306 | Q9BQ39 | |
| ASNPLAHYDTTADEI | 226 | P35520 | |
| EDHSNRKSAYDPSSV | 1136 | Q5VT06 | |
| QKISHIPENFDDYVD | 2561 | Q5VT06 | |
| TYEDPTQAVHEFAKE | 601 | P29320 | |
| SNKDFSEHEFDPDSY | 981 | Q9Y4F3 | |
| SLATSIDPKEDHNYS | 291 | P32314 | |
| EHPDREYETIQFSSK | 181 | Q8NDH2 | |
| EFDEDVYNHKTPESN | 141 | Q96EB1 | |
| LAHKYGFPELEDSTS | 116 | Q96Q07 | |
| SPSDYHKVDEEFETV | 1126 | Q9NZM4 | |
| DADEPFTGSSKILYH | 476 | Q12864 | |
| YDSDKVPDEHFSTLL | 131 | Q9BRJ6 | |
| EQQSFDHYKPGSSET | 591 | Q96MH7 | |
| SEATDSDYEDALPKH | 2126 | Q7Z5N4 | |
| SHYASESLPSKKDQE | 256 | Q15043 | |
| NAEPTEEVYKHFASS | 326 | Q9UK39 | |
| YVEDAFKSDDDIHPQ | 111 | Q96HA8 | |
| LYDVDSKSPDLSKHD | 96 | Q9HCH3 | |
| HFPSLNESSAEVLEY | 101 | Q8TB24 | |
| DPFYTQGDSLTSEDH | 156 | Q8NFH5 | |
| TYEDPSLAVHEFAKE | 611 | Q9UF33 | |
| DVTAKYSPSDEELHR | 346 | Q15406 | |
| AFENSLHPDYITEKL | 246 | P21217 | |
| EEYHKRDFTEVLSPN | 441 | A2RTX5 | |
| IYSSHAKKPNVDADD | 56 | Q9HBM6 | |
| QFDIDYETKPSHDAL | 236 | Q6ZV65 | |
| ADSPSIDYAELLQHF | 741 | Q08AM6 | |
| DAYKTEDSDDIHFEP | 1026 | Q7Z3J3 | |
| SDPAFAYAQLTHDEL | 1216 | Q6WKZ4 | |
| STEFEKPSENYHQDP | 336 | Q9BQF6 | |
| EEDGNYLHPSLFASK | 291 | Q12872 | |
| KVYDQPFHSSALEKE | 176 | Q9H668 | |
| DPYKIFTHDSFEKAE | 141 | Q32P41 | |
| ESFHNKGYEEDVPSD | 216 | Q8NB59 | |
| SHDLPTSEQLKDVAY | 581 | Q96KN7 | |
| DKYSKFDENGLPTHD | 696 | P49589 | |
| SFEYTGHDPTANKDS | 2846 | Q8WUY3 | |
| YFVAKEDPSSQEEAH | 401 | A4FU49 | |
| LEYEIKTNHPDSASE | 26 | Q8WVK7 | |
| KFEPHLYSLDSNSDD | 156 | Q9BSW7 | |
| YHSKNPEVDDSSAQK | 36 | Q4G0N0 | |
| EDFDEKHSIYPSEKS | 291 | Q68DH5 | |
| NSTDHAQGDYPKDIF | 111 | Q9UI40 | |
| SKFSHDADPEVSYNS | 711 | Q13200 | |
| YESFEDPAGTIDKFH | 2141 | Q6ZNJ1 | |
| PLEEQKELHYASLSF | 511 | O15389 | |
| PGYDSESKEFNAEVH | 181 | P46777 | |
| ADDNTDPPHYEETSF | 36 | Q13621 | |
| EAEFHKPDYGDTLSS | 596 | Q9C0D5 | |
| SNPAYREDIEASKDH | 246 | Q6UW49 | |
| HAAKDSSDPNELYVN | 151 | O15160 | |
| HYPLEEEKTDCQESS | 1691 | Q9P2P6 | |
| HFSVNDSKYIPVEDL | 46 | O15047 | |
| INHLFGPKDSEDSYD | 96 | P45381 | |
| PVYTESTDDKHLKFQ | 1076 | P25054 | |
| YSFDSRHKPAFTEED | 946 | O75153 | |
| ESYSEPQSKHFSEQL | 596 | Q96JI7 | |
| ETPYSEEDFQHLQKE | 106 | Q9H081 | |
| LEIDEETYLSSFKPH | 951 | P42285 | |
| YEEFQEHKTEKPSLS | 776 | O60673 | |
| SKTLYNLFHEDPEEE | 996 | Q0IIM8 | |
| TSDIDNPSHFEKQYE | 191 | Q8IXW5 | |
| DSESPHKYHVQFASD | 201 | Q14159 | |
| EYKASNPHASFSEEA | 571 | Q5XPI4 | |
| HASLEDKSSNSYSPE | 1351 | Q9HCK1 | |
| STAEKLLREFYPHSD | 1106 | Q8NDW8 | |
| DSDYSEPEHKLQRTS | 551 | Q9ULM0 | |
| KDYPSSENLHRNEDS | 896 | Q9UJU3 | |
| FSEEEFSNQSHPKDY | 106 | Q9Y2H8 | |
| FHAIDEYKPQDATTN | 31 | P37837 | |
| YDPDDHLIEEVTSKN | 116 | Q9NV66 | |
| TAYLFSPDHSDEKLI | 1171 | Q9BXT5 | |
| SSNYPEEFEKLLHQE | 2296 | O15050 | |
| SIKDNSFQYTIPHDD | 36 | Q96ME7 | |
| TDDALVYSTFLLHDP | 106 | P21754 | |
| HTTEKPTDAYGELDF | 66 | Q8TD43 | |
| YNDSSCKELHPDEID | 1541 | Q8NFA0 | |
| QLEELEKAFNESHYP | 116 | A6NJT0 | |
| LPTHSKRTYDSFQDE | 381 | Q5H9K5 | |
| FDDTNEKFYDSHPVA | 641 | O75132 | |
| SDSKRHLTPEEEEYA | 456 | P41229 | |
| EAKAFPSDHYAIESQ | 161 | Q16719 | |
| LLALDKDSFSDPYAH | 1151 | Q9NZM1 |